Literature DB >> 1365851

Pretreatment with aldosterone or corticosterone blocks the memory-enhancing effects of nimodipine, captopril, CGP 37,849, and strychnine in mice.

C Mondadori1, C Gentsch, B Hengerer, T Ducret, J Borkowski, A Racine, R Lederer, A Haeusler.   

Abstract

Oral pretreatment with aldosterone or corticosterone blocked the memory-enhancing effects of the calcium antagonist nimodipine, the ACE inhibitor captopril, the NMDA blocker CGP 37,849, and the glycine antagonist strychnine in a passive-avoidance test in mice. The memory-disturbing effects of phenobarbitone, diazepam, CGP 37,849 and scopolamine were not influenced by the hormonal pretreatment. These findings could indicate the involvement of a steroid-sensitive mechanism in drug-induced improvement of memory. In the light of clinical observations showing elevated cortisol levels in Alzheimer patients, the results might also explain why only a limited number of these patients respond to therapy with memory enhancers.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1365851     DOI: 10.1007/bf02247712

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  28 in total

1.  A GENERALIZED WILCOXON TEST FOR COMPARING ARBITRARILY SINGLY-CENSORED SAMPLES.

Authors:  E A GEHAN
Journal:  Biometrika       Date:  1965-06       Impact factor: 2.445

2.  Aldosterone receptors are involved in the mediation of the memory-enhancing effects of piracetam.

Authors:  C Mondadori; A Häusler
Journal:  Brain Res       Date:  1990-08-06       Impact factor: 3.252

3.  Nimodipine facilitates associative learning in aging rabbits.

Authors:  R A Deyo; K T Straube; J F Disterhoft
Journal:  Science       Date:  1989-02-10       Impact factor: 47.728

4.  Experiments with UCB 6215, a drug which enhances acquisition in rats: its effects compared with those of metamphetamine.

Authors:  O L Wolthuis
Journal:  Eur J Pharmacol       Date:  1971 Nov-Dec       Impact factor: 4.432

5.  Pharmacological modulation of memory: trends and problems.

Authors:  C Mondadori
Journal:  Acta Neurol Scand Suppl       Date:  1981

6.  Protein synthesis and memory: a review.

Authors:  H P Davis; L R Squire
Journal:  Psychol Bull       Date:  1984-11       Impact factor: 17.737

7.  Evidence that corticosterone is not an obligatory intermediate in aldosterone biosynthesis in the rat adrenal.

Authors:  A Häusler; G Monnet; C Borer; A S Bhatnagar
Journal:  J Steroid Biochem       Date:  1989       Impact factor: 4.292

8.  Nootropic effects of ACE inhibitors in mice.

Authors:  C Mondadori; P Etienne
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

9.  Steroid binding at sigma receptors suggests a link between endocrine, nervous, and immune systems.

Authors:  T P Su; E D London; J H Jaffe
Journal:  Science       Date:  1988-04-08       Impact factor: 47.728

10.  CGP 37849 and CGP 39551: novel and potent competitive N-methyl-D-aspartate receptor antagonists with oral activity.

Authors:  G E Fagg; H R Olpe; M F Pozza; J Baud; M Steinmann; M Schmutz; C Portet; P Baumann; K Thedinga; H Bittiger
Journal:  Br J Pharmacol       Date:  1990-04       Impact factor: 8.739

View more
  3 in total

1.  The memory-facilitating effects of the competitive NMDA-receptor antagonist CGP 37849 are steroid-sensitive, whereas its memory-impairing effects are not.

Authors:  C Mondadori; J Borkowski; C Gentsch
Journal:  Psychopharmacology (Berl)       Date:  1996-04       Impact factor: 4.530

2.  Delayed emergence of effects of memory-enhancing drugs: implications for the dynamics of long-term memory.

Authors:  C Mondadori; B Hengerer; T Ducret; J Borkowski
Journal:  Proc Natl Acad Sci U S A       Date:  1994-03-15       Impact factor: 11.205

3.  Reversal of cycloheximide-induced memory disruption by AIT-082 (Neotrofin) is modulated by, but not dependent on, adrenal hormones.

Authors:  Rongzi Yan; Quang Nguyen; James Gonzaga; Mai Johnson; Ronald F Ritzmann; Eve M Taylor
Journal:  Psychopharmacology (Berl)       Date:  2003-02-26       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.